Blogs (12)

CQ211 is a Potent and Selective RIOK2 Inhibitor

CQ211 is a selective RIOK2 inhibitor (Kd=6.1 nM). CQ211 exhibits anti-proliferation inhibition activity against multiple cancer cell lines.
Lapatinib is a Potent Inhibitor of the ErbB-2 and EGFR Tyrosine Kinase Domains

Lapatinib is a potent inhibitor of the ErbB-2 and EGFR tyrosine kinase domains with IC50 values against purified EGFR and ErbB-2 of 10.2 and 9.8 nM, respectively.
Rebeccamycin, an Antitumor Antibiotic, Inhibits DNA Topoisomerase I

Rebeccamycin, an antitumor antibiotic, inhibits DNA topoisomerase I. Rebeccamycin can be used for leukemia research.
DS17701585 is a Highly Selective, Orally Active EP300 and CBP Inhibitor

DS17701585 is a highly selective and orally active EP300 and CBP inhibitor and DS17701585 can be used for cancer research.
Pitstop 2 is a Clathrin Inhibitor which Inhibits Clathrin-Mediated Endocytosis (CME)

Pitstop 2 is a clathrin inhibitor which inhibits clathrin-mediated endocytosis (CME) by associating with the terminal domain of clathrin.
Actinomycin D Inhibits DNA Repair and Induces Autophagy

Actinomycin D (Dactinomycin) is an autophagy activator inhibiting DNA repair with an IC50 of 0.42 μM.
LTX-315 is an Oncolytic Peptide with Potent Anticancer Activity

LTX-315 is an oncolytic peptide with potent anticancer activity.
β-Amanitin is a cyclic peptide toxin, inhibits eukaryotic RNA polymerase II and III and protein synthesis.

β-Amanitin is a cyclic peptide toxin, inhibits eukaryotic RNA polymerase II and III. It inhibits DNA transcription, and protein synthesis.
Vatalanib (PTK787) is an Inhibitor of VEGFR2/KDR

Vatalanib is an inhibitor of VEGFR2/KDR. Vatalanib induces inhibition of the angiogenic response to VEGF and PDGF.
Gardiquimod is a TLR7/8 Agonist and Could Inhibit HIV-1 Infection

Gardiquimod is a TLR7/8 agonist and can inhibit HIV-1 infection.

Name
Email *

	Sorry, but the email address you supplied was invalid.